idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial). Br J Haematol. 2018 Oct;183 [...] F, Gottlieb J, Bara C, Becker JU, Broecker V. (2010). Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transpl. 10, 2017-25 Koenecke C, Hertenstein B
gene expression predict differential drug sensitivity in newly diagnosed and recurrent glioblastoma. Cancers (Basel). 2020 Feb 24;12(2). MYNAREK M, VON HOFF K, PIETSCH T, OTTENSMEIER H, WARMUTH-METZ M, [...] , REUSS D, SAHM F, JONES DTW, CAPPER D, VON DEIMLING A. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478
, 2023 It has been two and a half years since Peter Konrad was diagnosed with ALS (amyotrophic lateral sclerosis). The sports journalist, who wrote for the Peiner Allgemeine Zeitung newspaper and
. eCollection 2023. Comparison of Prenatal and Postmortem Diagnoses from 251 Fetal Autopsies: High Rate of Placenta Pathologies, Low Rate of Discrepancies Suhren JT , Hussein K, Kreipe H , Schaumann
Prevalence Estimation of Chronic Diseases Based on Outpatient Diagnoses in German Claims Data]. Health Services 2023;85:1-8. DOI: 10.1055/a-2052-6477 *-shared first authorship Tetzlaff F, Nowossadeck
/j.arbres.2019.03.001. Epub 2019 May 30.PMID: 31153743 2019 Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology. Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, [...] 2017. PMID: 28107454 Free PMC article. The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Greulich T, Nell C, Hohmann D,
individual susceptibility to infections so that we can prevent, diagnose and treat infections in a tailored manner. ‘This is a great day for infection research and thus for people who are particularly [...] or postmenopausal With invasive, untreated HER2+ breast cancer Diagnosed no more than 6 weeks prior to registration Low, medium or high clinical risk of recurrence 2. Study design: Multicentre Interventional
by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation. Neuro Oncol 2013; 15(10): 1405-1412 Wilsdorf N, Eiz-Vesper B, Henke-Gendo C
, the process often progresses insidiously and is difficult to diagnose, especially in the early stages. Thus, the signs of minimal hepatic encephalopathy, a neurological disorder that can occur in
16, 2024 Liane Frischmuth died just a few months after being diagnosed with cancer - a brain tumor had cut off the blood supply to her heart despite intensive treatment in the MHH's neurosurgery [...] quickly out of breath at a young age," says Keidel. "I was later diagnosed with holes in my lungs, and soon I couldn't go about my daily life without an oxygen mask." When the physicians raised the